BioSpace News Archive

Vesigen Therapeutics, Inc showcased eight data presentations at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting held May 16-20, 2023 in Los Angeles.

Pieris Pharmaceuticals, Inc. announced the presentation of preclinical data from the Company’s inhaled Jagged-1 targeting program, PRS-400, at the annual American Thoracic Society (ATS) International Conference being held in Washington, D.C. May 19-24, 2023.

T2 Biosystems, Inc. announced today it has rescheduled its first quarter 2023 financial results reporting to before market open on Tuesday, May 23, 2023.

RayzeBio, Inc. today announced that the Company will be presenting data for its lead clinical program, RYZ101 (Ac225 DOTATATE) at two upcoming medical conferences as well as presentations on preclinical programs.

Microbot Medical Inc., the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, announced a highly successful extended joint pre- clinical animal study held at a leading European-based research lab.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) today announced that it presented additional biomarker data from its completed Phase 1 clinical trial of KER-012 in healthy post-menopausal women at the American Thoracic Society (“ATS”) 2023 International Conference.

Quanta Therapeutics, a privately-held biopharmaceutical company pioneering targeted therapies to treat RAS-driven cancers, today announced a $50.7 million Series D financing.

XBiotech Inc. (NASDAQ: XBIT) today reports that the FDA’s Division of Rheumatology has authorized the Company to initiate a Phase II clinical study to test Natrunix™ as a treatment for Rheumatoid Arthritis.

Scribe Therapeutics Inc., a genetic medicines company unlocking the potential of CRISPR to transform human health, announced that the Company will participate in the following upcoming investor conferences in May and June.

ImmunityBio, Inc., a clinical-stage immunotherapy company, announced that Executive Chairman and Global Chief Scientific and Medical Officer Dr. Patrick Soon-Shiong, M.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 7, 2023, at 10:00 am Eastern Time at the Marriott Marquis, New York.